Comparison effect of oral dydrogesterone with vaginalprogesterone in the treatment of infertility by intrauterine sperm injection

compression of oral Dydrogestrone with vaginal Progestron in IUI successfull in patient with unexplained infertility

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130311012782N47

Enrollment

210

Registered

2020-06-10

Start date

2020-08-22

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unexplained infertility. unexplained infertility

Interventions

Intervention 1: Intervention Group 1: Infertile women treated with intrauterine sperm injection with oral administration of 10 mg oral tablets of Dydrogesterone, one tablet per night for 16 days. Inte

Eligibility

Sex/Gender

Female

Age

No minimum to 45 Years

Inclusion criteria

Inclusion criteria: Visiting women with unexplained infertility Indications for treatment of intrauterine sperm injection Patient's consent to participate in the study Maximum 45 years old

Exclusion criteria

Exclusion criteria: Do other infertility treatments at the same time

Design outcomes

Primary

Measure	Time frame
Fertility success. Timepoint: 16 days after treatment. Method of measurement: Measurement of beta HCG.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHatav Ghasemi Tehrani

Esfahan University of Medical Sciences

tehrani@med.mui.ac.ir+98 31 3668 5555

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026